Clinical Trial Update: Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE) [Phase 3]

View source ↗

Summary

Phase 3 trial update for Air versus Oxygen in intermediate-risk pulmonary embolism completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: Ministry of Health, Spain | Conditions: Pulmonary Embolism | Phase 3 | Status: COMPLETED